# Indivior Pharmaceuticals, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:6d72c096-7cde-4da6-8ffe-a69c12c78414 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/indivior-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 24 | | Claims under review | 1 | | Evidence records | 5 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:45:45.751176+00:00 | | Last reviewed | 2026-10-17T04:45:45.751176+00:00 | ## Identity - Legal name: Indivior Pharmaceuticals, Inc. - Display name: Indivior Pharmaceuticals, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T22:54:37.489423+00:00 | | Completeness | 0.409 | | Record Quality | 0.834 | | Directors | 13 | | Committees | 1 | | Governance events | 10 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Advanced ANGLE Vectura: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:6 - Garrett Lordstown Hertz: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:9 - Juliet Thompson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:11 - Lordstown Hertz Barbara: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:13 - Mark Stejbach: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:14 - Medical Center: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2024-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:15 - Scholar Daniel: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:16 - Tony Kingsley: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:17 - Barbara Ryan: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:7 - Daniel Ninivaggi: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:8 - David Wheadon: Independent Chair of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:5 - Joe Ciaffoni: Director, Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Chief Executive Officer (member). claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:10 - Keith Humphreys: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:12 ## Committees - Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: Joe Ciaffoni (member, unknown). committee_id=alpha:committee:indivior-pharmaceuticals-inc:chief-executive-officer ## Executive leadership - Joseph Ciaffoni: Chief Executive Officer and Executive Director [CEO]. Status: current. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:21 - Woodrow Anderson: Senior Vice President Group Controller [CAO]. Status: current. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:24 - Christian Heidbreder: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:18 - Jeff Burris: Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:19 - Joe Ciaffoni: Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:20 - Pat Barry: Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:22 - Ryan Preblick: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:23 ## Governance events - CEO_CHANGED: Joseph Ciaffoni executive of Indivior Pharmaceuticals, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1g8jp4r17zw3y5 - EXECUTIVE_APPOINTED: Woodrow Anderson executive of Indivior Pharmaceuticals, Inc., effective 2026-02-26. Effective: 2026-02-26. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:t4xei515fxyen - DIRECTOR_APPOINTED: Garrett Lordstown Hertz seat on Indivior Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:qb8rj1n47elx - DIRECTOR_APPOINTED: Scholar Daniel seat on Indivior Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1uoq6f1reesqz - DIRECTOR_APPOINTED: Tony Kingsley seat on Indivior Pharmaceuticals, Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:l7qahs8sm2fa - DIRECTOR_APPOINTED: Juliet Thompson seat on Indivior Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1co8z7311c34h - DIRECTOR_APPOINTED: Medical Center seat on Indivior Pharmaceuticals, Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:16hfjenbua7ud - DIRECTOR_APPOINTED: Lordstown Hertz Barbara seat on Indivior Pharmaceuticals, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:x2j4u71dlbmjh - DIRECTOR_APPOINTED: Advanced ANGLE Vectura seat on Indivior Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1k6jgui164yl3a - DIRECTOR_APPOINTED: Mark Stejbach seat on Indivior Pharmaceuticals, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:45:45.751176+00:00. event_id=alpha:event:transition:1cghfe11wat5gt ## Scoped resources - `alpha://company/indivior-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record - `alpha://company/indivior-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/indivior-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/indivior-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=board - `alpha://company/indivior-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/indivior-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/indivior-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/indivior-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/indivior-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/indivior-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/indivior-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/indivior-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/indivior-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/indivior-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/indivior-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/indivior-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/indivior-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/indivior-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/indivior-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/indivior-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=events - `alpha://company/indivior-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/indivior-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/indivior-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - David Wheadon: Independent Chair of the Board. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Advanced ANGLE Vectura: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Barbara Ryan: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Daniel Ninivaggi: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Garrett Lordstown Hertz: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Joe Ciaffoni: Director, Chief Executive Officer. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Juliet Thompson: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:11. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Keith Humphreys: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Lordstown Hertz Barbara: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Mark Stejbach: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:14. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Medical Center: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:15. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Scholar Daniel: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:16. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Tony Kingsley: Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:17. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9. - Christian Heidbreder: Chief Scientific Officer. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Jeff Burris: Chief Legal Officer. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Joe Ciaffoni: Chief Executive Officer. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Joseph Ciaffoni: Chief Executive Officer and Executive Director. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:21. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c61c269590f4a60efcc616439f31adb39ecf84ab0726b77d387da34697775126. - Pat Barry: Chief Commercial Officer. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Ryan Preblick: Chief Financial Officer. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e. - Woodrow Anderson: Senior Vice President Group Controller. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:leadership_role:24. Valid from: 2026-02-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a0efd551e43b71f10f00d11cf1704887df50af33e662d163b43968421ea6a462. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Indivior Pharmaceuticals, Inc.. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ba09b14cebcb7892120403ea5a7936b60cfd2163114f395deba946b26d5c5d57. ## Entity Status - Public listing published. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ba09b14cebcb7892120403ea5a7936b60cfd2163114f395deba946b26d5c5d57. ## Published Fact - US. Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ba09b14cebcb7892120403ea5a7936b60cfd2163114f395deba946b26d5c5d57. ## Security Listing - INDV (NASDAQ). Claim: alpha:claim:company:6d72c096-7cde-4da6-8ffe-a69c12c78414:security_listing:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:ba09b14cebcb7892120403ea5a7936b60cfd2163114f395deba946b26d5c5d57. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:ba09b14cebcb7892120403ea5a7936b60cfd2163114f395deba946b26d5c5d57: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc). - alpha:projection-evidence:document:a12ba3795f9d48e76b3fa88cf10be1d9fa8b84d5ced335a3368c12cf4266a32e: [SEC DEF 14A 0001104659-26-035480](https://www.sec.gov/Archives/edgar/data/1625297/000110465926035480/tm267639d1_def14a.htm). - alpha:projection-evidence:document:689fbe7526c173343503ae023d9526115a85533be4440e5997bf323852d613d9: [DEF 14A tm267639d1_def14a.htm](https://www.sec.gov/Archives/edgar/data/1625297/000110465926035480/tm267639d1_def14a.htm). - alpha:projection-evidence:document:c61c269590f4a60efcc616439f31adb39ecf84ab0726b77d387da34697775126: [INDV 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1625297/000162828026012237/indv-20251231.htm). - alpha:projection-evidence:document:a0efd551e43b71f10f00d11cf1704887df50af33e662d163b43968421ea6a462: [INDV 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1625297/000162828026012237/indv-20251231.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/indivior-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/indivior-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/indivior-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/indivior-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T22:54:37.288648+00:00; recorded 2026-10-17T22:54:37.288648+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.